These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 34374130)
1. Gut microbiota enhances the chemosensitivity of hepatocellular carcinoma to 5-fluorouracil in vivo by increasing curcumin bioavailability. Jin M; Kong L; Han Y; Zhang S Phytother Res; 2021 Oct; 35(10):5823-5837. PubMed ID: 34374130 [TBL] [Abstract][Full Text] [Related]
2. RBFOX3 Regulates the Chemosensitivity of Cancer Cells to 5-Fluorouracil via the PI3K/AKT, EMT and Cytochrome-C/Caspase Pathways. Liu T; Wu X; Li Y; Lu W; Zheng F; Zhang C; Long Q; Qiu H; Li Y; Ge Q; Chen M; Yu X; Chen W; Zhang H; Huang W; Luo M; Deng W; Li L Cell Physiol Biochem; 2018; 46(4):1365-1380. PubMed ID: 29689552 [TBL] [Abstract][Full Text] [Related]
3. Zn(II)-curcumin solid dispersion impairs hepatocellular carcinoma growth and enhances chemotherapy by modulating gut microbiota-mediated zinc homeostasis. Wu R; Mei X; Ye Y; Xue T; Wang J; Sun W; Lin C; Xue R; Zhang J; Xu D Pharmacol Res; 2019 Dec; 150():104454. PubMed ID: 31526871 [TBL] [Abstract][Full Text] [Related]
4. Hydrazinocurcumin and 5-fluorouracil enhance apoptosis and restrain tumorigenicity of HepG2 cells via disrupting the PTEN-mediated PI3K/Akt signaling pathway. Zhou Y; Zhang M; Zhang Z; Jia Y; Zhang C; Peng L Biomed Pharmacother; 2020 Sep; 129():109851. PubMed ID: 32559627 [TBL] [Abstract][Full Text] [Related]
5. Low curcumin concentration enhances the anticancer effect of 5-fluorouracil against colorectal cancer. Zheng X; Yang X; Lin J; Song F; Shao Y Phytomedicine; 2021 May; 85():153547. PubMed ID: 33812170 [TBL] [Abstract][Full Text] [Related]
6. Suberoylanilide hydroxamic acid enhances chemosensitivity to 5-fluorouracil in hepatocellular carcinoma via inhibition of thymidylate synthase. Liao B; Liang H; Chen J; Liu Q; Zhang B; Chen X Tumour Biol; 2015 Dec; 36(12):9347-56. PubMed ID: 26108995 [TBL] [Abstract][Full Text] [Related]
7. MEL-pep, an analog of melittin, disrupts cell membranes and reverses 5-fluorouracil resistance in human hepatocellular carcinoma cells. Ke M; Dong J; Wang Y; Zhang J; Zhang M; Wu Z; Lv Y; Wu R Int J Biochem Cell Biol; 2018 Aug; 101():39-48. PubMed ID: 29800725 [TBL] [Abstract][Full Text] [Related]
8. Dual sphingosine kinase inhibitor SKI-II enhances sensitivity to 5-fluorouracil in hepatocellular carcinoma cells via suppression of osteopontin and FAK/IGF-1R signalling. Grbčić P; Tomljanović I; Klobučar M; Kraljević Pavelić S; Lučin K; Sedić M Biochem Biophys Res Commun; 2017 Jun; 487(4):782-788. PubMed ID: 28433634 [TBL] [Abstract][Full Text] [Related]
9. Curcumin inhibits proliferation of hepatocellular carcinoma cells through down regulation of DJ-1. Han L; Wang Y; Sun S Cancer Biomark; 2020; 29(1):1-8. PubMed ID: 32417759 [TBL] [Abstract][Full Text] [Related]
10. The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III. Jiang H; Dong Q; Luo X; Shi B; Wang H; Gao H; Kong J; Zhang J; Li Z Cancer Lett; 2014 Jan; 342(1):113-20. PubMed ID: 24007863 [TBL] [Abstract][Full Text] [Related]
11. Caffeine enhances the anti-tumor effect of 5-fluorouracil via increasing the production of reactive oxygen species in hepatocellular carcinoma. Wang Z; Gu C; Wang X; Lang Y; Wu Y; Wu X; Zhu X; Wang K; Yang H Med Oncol; 2019 Oct; 36(12):97. PubMed ID: 31664534 [TBL] [Abstract][Full Text] [Related]
12. 5-Fluorouracil combined with apigenin enhances anticancer activity through mitochondrial membrane potential (ΔΨm)-mediated apoptosis in hepatocellular carcinoma. Hu XY; Liang JY; Guo XJ; Liu L; Guo YB Clin Exp Pharmacol Physiol; 2015 Feb; 42(2):146-53. PubMed ID: 25363523 [TBL] [Abstract][Full Text] [Related]
13. [Curcumin combined with 5-FU promotes autophagy and down-regulates the expression of Yes-associated protein (YAP) in hepatocellular carcinoma cells]. Wang X; Zhu J Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Oct; 37(10):917-922. PubMed ID: 34670669 [TBL] [Abstract][Full Text] [Related]
14. Curcumin Reverses 5-Fluorouracil Resistance by Promoting Human Colon Cancer HCT-8/5-FU Cell Apoptosis and Down-regulating Heat Shock Protein 27 and P-Glycoprotein. He WT; Zhu YH; Zhang T; Abulimiti P; Zeng FY; Zhang LP; Luo LJ; Xie XM; Zhang HL Chin J Integr Med; 2019 Jun; 25(6):416-424. PubMed ID: 30484020 [TBL] [Abstract][Full Text] [Related]
15. NOD1 inhibits proliferation and enhances response to chemotherapy via suppressing SRC-MAPK pathway in hepatocellular carcinoma. Ma X; Qiu Y; Zhu L; Zhao Y; Lin Y; Ma D; Qin Z; Sun C; Shen X; Li T; Han L J Mol Med (Berl); 2020 Feb; 98(2):221-232. PubMed ID: 31872284 [TBL] [Abstract][Full Text] [Related]
16. Aloperine induces apoptosis and G2/M cell cycle arrest in hepatocellular carcinoma cells through the PI3K/Akt signaling pathway. Liu JS; Huo CY; Cao HH; Fan CL; Hu JY; Deng LJ; Lu ZB; Yang HY; Yu LZ; Mo ZX; Yu ZL Phytomedicine; 2019 Aug; 61():152843. PubMed ID: 31039533 [TBL] [Abstract][Full Text] [Related]
17. USP22 knockdown enhanced chemosensitivity of hepatocellular carcinoma cells to 5-Fu by up-regulation of Smad4 and suppression of Akt. Zhang J; Luo N; Tian Y; Li J; Yang X; Yin H; Xiao C; Sheng J; Li Y; Tang B; Li R Oncotarget; 2017 Apr; 8(15):24728-24740. PubMed ID: 28445968 [TBL] [Abstract][Full Text] [Related]
18. Smad4 sensitizes colorectal cancer to 5-fluorouracil through cell cycle arrest by inhibiting the PI3K/Akt/CDC2/survivin cascade. Zhang B; Leng C; Wu C; Zhang Z; Dou L; Luo X; Zhang B; Chen X Oncol Rep; 2016 Mar; 35(3):1807-15. PubMed ID: 26647806 [TBL] [Abstract][Full Text] [Related]
19. Nogo-B receptor promotes the chemoresistance of human hepatocellular carcinoma via the ubiquitination of p53 protein. Dong C; Zhao B; Long F; Liu Y; Liu Z; Li S; Yang X; Sun D; Wang H; Liu Q; Liang R; Li Y; Gao Z; Shao S; Miao QR; Wang L Oncotarget; 2016 Feb; 7(8):8850-65. PubMed ID: 26840457 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of Orai1-mediated Ca Tang BD; Xia X; Lv XF; Yu BX; Yuan JN; Mai XY; Shang JY; Zhou JG; Liang SJ; Pang RP J Cell Mol Med; 2017 May; 21(5):904-915. PubMed ID: 27878958 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]